Tuberculosis and Respiratory Diseases

The Korean Academy of Tuberculosis and Respiratory Diseases (대한결핵및호흡기학회)
권호 표지

Relationship between Dyspnea and Disease Severity, Quality of Life, and Social Factor in Patients with Chronic Obstructive Pulmonary Disease

만성폐쇄성폐질환자에서 질병 중증도 및 삶의 질을 비롯한 사회적 요인과 호흡곤란과의 관계

  • Kim, Eun-Jin (Department of Internal Medicine, School of Medicine, Kyungpook National University) ;
  • Park, Jae-Hyung (Department of Internal Medicine, School of Medicine, Kyungpook National University) ;
  • Yoon, Suk-Jin (Department of Internal Medicine, School of Medicine, Kyungpook National University) ;
  • Lee, Seung-Jun (Department of Internal Medicine, School of Medicine, Kyungpook National University) ;
  • Cha, Seung-Ick (Department of Internal Medicine, School of Medicine, Kyungpook National University) ;
  • Park, Jae-Yong (Department of Internal Medicine, School of Medicine, Kyungpook National University) ;
  • Jung, Tae-Hoon (Department of Internal Medicine, School of Medicine, Kyungpook National University) ;
  • Kim, Chang-Ho (Department of Internal Medicine, School of Medicine, Kyungpook National University)
  • 김은진 (경북대학교 의과대학 내과학교실) ;
  • 박재형 (경북대학교 의과대학 내과학교실) ;
  • 윤석진 (경북대학교 의과대학 내과학교실) ;
  • 이승준 (경북대학교 의과대학 내과학교실) ;
  • 차승익 (경북대학교 의과대학 내과학교실) ;
  • 박재용 (경북대학교 의과대학 내과학교실) ;
  • 정태훈 (경북대학교 의과대학 내과학교실) ;
  • 김창호 (경북대학교 의과대학 내과학교실)
  • Received : 2005.10.12
  • Accepted : 2006.04.18
  • Published : 2006.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Chronic obstructive pulmonary disease(COPD) is categorized by the percentage of the predicted $FEV_1$(Forced expiratory volume in 1 second) result which is highly correlated with disease severity(morbidity and mortality). In COPD patients, dyspnea seems to be different from disease severity. We investigated whether dyspnea is correlated with disease severity, as measured by $FEV_1$, quality of life(QoL), occupation, and supporting level of family members and neighbors. Method: Thirty-six clinically stable patients with chronically irreversible airflow limitation were enrolled. We used the Medical Research Council(MRC) dyspnea scale to assess the level of dyspnea and the Korean St. Goerge's respiratory questionnaire(SGRQ) as measure the QoL. Result: The mean percentage of the predicted $FEV_1$ was 32.0%. Dyspnea was not correlated with GOLD stage using $FEV_1$(p=0.114). With deteriorating level of dyspnea the scores of symptoms(p=0.041), activity(p=0.004), impact(p=0.001), and total SGRQ score(p<0.001) were significantly increased. Dyspnea was not correlated with the level of occupation(p=0.259). The supporting level of family members and neighbors was significantly negatively correlated with dyspnea scale(p=0.011). Conclusion: In the management of COPD patients, we have to remember that the level of subjective dyspnea is correlated with QoL(symptom, activity and impact on society) and social supporting level as well as GOLD stage($FEV_1$).

연구배경: 만성폐쇄성폐질환은 질병의 중증도를 추정 정상치에 대한 $FEV_1$의 백분율을 기준으로 분류해 왔다. 그러나, 같은 폐기능 검사소견을 보이는 환자들 사이에서도 환자가 느끼는 주관적 호흡곤란에는 차이가 있다. 본 연구에서는 호흡곤란이 $FEV_1$를 비롯하여, 건강관련 삶의 질, 주변으로부터 받는 도움의 정도, 직업 등에 영향을 받는지에 대해 알아보고자 하였다. 방법: 2002년 6월부터 2004년 5월까지 경북대학교병원 호흡기 내과에서 만성폐쇄성폐질환으로 추적관찰 중이며, 임상적으로 안정되어 있고 비가역적인 폐쇄성 폐기능 장애를 가진 환자 36명을 대상으로 하였다. 만성 폐쇄성 폐질환의 병기는, GOLD 병기를 따랐으며, 호흡곤란 척도는 MRC 호흡곤란 척도를 사용하였다. 건강 관련 삶의 질은 한국어 St. Goerge's respiratory questionnaire(SGRQ)를 사용하였다. 결과: 환자들의 평균 $FEV_1$은 추정 정상치의 32.0%였다. GOLD 병기와 호흡곤란 정도사이에 유의한 상관관계는 없었다(p=0.114). 호흡곤란이 심할수록 SGRQ 값의 증상(symptom)(p=0.041), 활동력(activity)(p=0.004), 영향력(impact)(p=0.001), 총점(total)(p<0.001) 수치 모두에서 의미있게 높은 수치를 보였다. 호흡곤란 정도와 직업간에 의미있는 상관관계는 없었으며(p=0.259), 호흡곤란이 심할수록 환자가 주변으로부터 받는 도움 정도는 적다고 느끼는 상관관계가 뚜렷하였다(p=0.011). 결론: 만성폐쇄성폐질환자의 진료에서 환자가 느끼는 주관적인 호흡곤란은 $FEV_1$에 따른 병기 외에도 건강관련 삶의 질 및 주변의 지지 정도와 더 연관성을 가질 수 있다는 점이 고려되어야 할 것으로 사료된다.

Keywords

References

  1. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global initiative for chronic obstructive lung disease(COPD) Workshop summary. Am J Respir Crit Care Med 2001;163:1256-76 https://doi.org/10.1164/ajrccm.163.5.2101039
  2. Fabbri LM, Hurd SS. Global strategy for the diagnosis, management, and prevention of Chronic Obstructive Lung Disease: 2003 updated. Eur Respir J 2003;22:1-2 https://doi.org/10.1183/09031936.03.00063703
  3. Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, et al. Harrison's principles of internal medicine. 16th ed. McGraw-Hill; 2005. p. 201
  4. Hajiro T, Nishimura K, Tsukino M, Ikeda A, Koyama H, Izumi T. Comparison of discriminative properties among disease-specific questionnaires for measuring heath-related quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:785-90 https://doi.org/10.1164/ajrccm.157.3.9703055
  5. Wolkove N, Dajezman E, Colacone A, Kreisman H. The relationship between pulmonary function and dyspnea in obstructive lung disease. Chest 1989; 96:1247-51 https://doi.org/10.1378/chest.96.6.1247
  6. Pearson MG, Bellamy D, Calverley PM, Honeybourne D, MacNee W, Rudolf M, et al. BTS guideline for the management of chronic obstructive pulmonary disease. Thorax 1997;52(Suppl):S1-28 https://doi.org/10.1136/thx.52.2008.S1
  7. Cooper CB, Tashkin DP. Recent developments in inhaled therapy in stable chronic obstructive pulmonary disease. BMJ 2005;330:640-4 https://doi.org/10.1136/bmj.330.7492.640
  8. van der Molen T, Willemse BW, Schokker S, ten Hacken NH, Postma DS, Juniper EF. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes 2003;1:13 https://doi.org/10.1186/1477-7525-1-13
  9. Curtis JR, Martin DP, Martin TR. Patient-assessed health outcomes in chronic lung disease: what are they, how do they help us, and where do we go from here? Am J Respir Crit Care Med 1997;156:1032-9 https://doi.org/10.1164/ajrccm.156.4.97-02011
  10. Curtis JR, Deyo RA, Hudson LD. Pulmonary rehabilitation in chronic respiratory insufficiency: 7. health-related quality of life among patients with chronic obstructive pulmonary disease. Thorax 1994; 49:162-70 https://doi.org/10.1136/thx.49.2.162
  11. Mahler DA. How should health-related quality of life be assessed in patients with COPD- Chest 2000;117: 54S-7S https://doi.org/10.1378/chest.117.2_suppl.54S
  12. Ferrer M, Alonso J, Morera J, Marrades RM, Khalaf A, Aguar MC, et al. Chronic obstructive pulmonary disease stage and health-related quality of life. Ann Intern Med 1997;127:1072-9 https://doi.org/10.7326/0003-4819-127-12-199712150-00003
  13. Fletcher CM, Elmes PC, Fairbairn AS, Wood CH. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br Med J 1959;(5147):257-66
  14. Jones PW, QuirkFH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation: The St. George's Rsepiratory Questionnaire. Am Rev Respir Dis 1992;145:1321-7 https://doi.org/10.1164/ajrccm/145.6.1321
  15. Jones PW, Quirk FH, Baveystock CM. The St. George's Respiratory Questionnaire. Respir Med 1991; 85(Suppl B):25-31 https://doi.org/10.1016/S0954-6111(06)80166-6
  16. Williams SJ, Bury MR. Impairment, disability and handcap in chronic respiratory illness. Soc Sci Med 1989;29:609-16 https://doi.org/10.1016/0277-9536(89)90180-9
  17. Mahler DA, Wells CK, Evaluation of clinical methods for rating dyspnea. Chest 1988;93:580-6 https://doi.org/10.1378/chest.93.3.580
  18. Hajiro T, Nishimura K, Tsukino M, Ikeda A, Oga T, Izumi T. A comparison of the level of dyspnea vs disease severity in indicating the health-related quality of life of patients with COPD. Chest 1999;116: 1632-7 https://doi.org/10.1378/chest.116.6.1632
  19. Okbadejo AA, Jones PW, Wedzicha JA. Quality of life in patients with chronic obstructive pulmonary disease and severe hypoxemia. Thorax 1996;51:44-7 https://doi.org/10.1136/thx.51.1.44